Neimeth International Pharmaceuticals Plc announced earnings results for the second quarter ended March 31, 2021. For the second quarter, the company announced sales was NGN 887.014 million compared to NGN 558.691 million a year ago. Operating income was NGN 217.553 million compared to NGN 28.585 million a year ago. Net income was NGN 207.097 million compared to net loss of NGN 26.056 million a year ago. Basic earnings per share from continuing operations was NGN 0.109 compared to basic loss per share from continuing operations of NGN 0.0137 a year ago. For the half year, sales was NGN 1,281.576 million compared to NGN 1,165.166 million a year ago. Operating income was NGN 70.626 million compared to NGN 124.063 million a year ago. Net income was NGN 28.309 million compared to NGN 56.595 million a year ago. Basic earnings per share from continuing operations was NGN 0.0149 compared to NGN 0.0298 a year ago.